Sex-Specific Association Between Nerve Growth Factor Polymorphism and Cardiac Vagal Modulation

Objective Substantial research has shown that anxiety disorders are associated with decreased cardiac vagal tone, which is a known risk factor for cardiac vulnerability. A functional nerve growth factor (NGF) polymorphism (rs6330, c.104C > T, p.Ala35Val) has been associated with anxiety such that in males but not females, T-allele carriers exhibit higher levels of trait anxiety. Here we investigate whether the nonsynonymous NGF variant has an effect on cardiac autonomic control. Methods From 705 adults initially screened for medical and psychiatric illnesses, a final cohort of 580 healthy Han Chinese (352 men, 228 women; mean [standard deviation] age = 34.46 [8.45] years) was included in the NGF genotyping (C/C: 428% [73.8%] and T-allele carriers: 152% [26.2%]). Short-term heart rate variability was used to assess cardiac autonomic function. Results There were significant genotype-by-sex interaction effects (p < .05) on high-frequency power (HF) and root mean square of successive heartbeat interval differences (RMSSD), both indices of cardiac vagal control. Even after adjusting for possible confounders, men with any T allele showed lower HF and RMSSD compared with men with the C/C genotype. Women, however, showed an opposite but nonsignificant pattern. Conclusions The studied NGF polymorphism modulates autonomic outflow to the heart in a sex-dependent manner. The findings support the view that male T-allele carriers are at increased susceptibility for anxiety by association with low vagal activity and suggest a potential sex-specific genetic link between the highly comorbid anxiety disorders and cardiovascular diseases.

[1]  D. Collier,et al.  Predicting outcomes following cognitive behaviour therapy in child anxiety disorders: the influence of genetic, demographic and clinical information. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[2]  Heidemarie K. Laurent,et al.  Salivary Nerve Growth Factor Reactivity to Acute Psychosocial Stress: A New Frontier for Stress Research , 2013, Psychosomatic medicine.

[3]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[4]  E. Lipov,et al.  Modulation of NGF by cortisol and the Stellate Ganglion Block - is this the missing link between memory consolidation and PTSD? , 2012, Medical hypotheses.

[5]  W. Fang,et al.  Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities. , 2012, Research in developmental disabilities.

[6]  Leonardo Franklin Fontenelle,et al.  Neurotrophic factors in obsessive-compulsive disorder , 2012, Psychiatry Research.

[7]  D. Collier,et al.  Neurotrophic gene polymorphisms and response to psychological therapy , 2012, Translational Psychiatry.

[8]  C. Beevers,et al.  Serotonin transporter promoter region (5-HTTLPR) polymorphism predicts resting respiratory sinus arrhythmia. , 2011, Psychophysiology.

[9]  S. Govoni,et al.  NGF and heart: Is there a role in heart disease? , 2011, Pharmacological research.

[10]  V. Burt,et al.  DSM-V: modifying the postpartum-onset specifier to include hypomania , 2010, Archives of Women's Mental Health.

[11]  A. Yang,et al.  BDNF Val66Met polymorphism alters sympathovagal balance in healthy subjects , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[12]  J. Denollet,et al.  Anxiety and risk of incident coronary heart disease: a meta-analysis. , 2010, Journal of the American College of Cardiology.

[13]  N. Dragoș,et al.  Genetic contributions of the serotonin transporter to social learning of fear and economic decision making. , 2009, Social cognitive and affective neuroscience.

[14]  R. Logier,et al.  [Heart rate variability. Applications in psychiatry]. , 2009, L'Encephale.

[15]  D. Servant,et al.  La variabilité de la fréquence cardiaque. Intérêts en psychiatrie , 2009 .

[16]  A. Hamm,et al.  Individual differences in fear-potentiated startle as a function of resting heart rate variability: implications for panic disorder. , 2009, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[17]  Mircea Miclea,et al.  Reduced heart rate variability and vagal tone in anxiety: Trait versus state, and the effects of autogenic training , 2009, Autonomic Neuroscience.

[18]  J. Gallinat,et al.  Gender-dependent Association of a Functional NGF Polymorphism with Anxiety-related Personality Traits , 2008, Pharmacopsychiatry.

[19]  H. Katus,et al.  Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart. , 2008, Journal of molecular and cellular cardiology.

[20]  I. Nyklíček,et al.  Depression and anxiety as predictors of heart rate variability after myocardial infarction , 2007, Psychological Medicine.

[21]  F. Wilhelm,et al.  Autonomic and Respiratory Characteristics of Posttraumatic Stress Disorder and Panic Disorder , 2007, Psychosomatic medicine.

[22]  F. Dudbridge,et al.  An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  Jenny H. Pan,et al.  Nerve growth factor acutely potentiates synaptic transmission in vitro and induces dendritic growth in vivo on adult neurons in airway parasympathetic ganglia. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[24]  Gurjinder Kaur,et al.  Estrogen regulation of neurotrophin expression in sympathetic neurons and vascular targets , 2007, Brain Research.

[25]  Bruce H. Friedman,et al.  An autonomic flexibility–neurovisceral integration model of anxiety and cardiac vagal tone , 2007, Biological Psychology.

[26]  H. Danker-Hopfe,et al.  Nerve growth factor serum concentrations rise after successful cognitive–behavioural therapy of generalized anxiety disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[27]  Hagit Cohen,et al.  Power spectrum analysis and cardiovascular morbidity in anxiety disorders , 2006, Autonomic Neuroscience.

[28]  J. Feldon,et al.  Influence of differential housing on emotional behaviour and neurotrophin levels in mice , 2006, Behavioural Brain Research.

[29]  Paul D. Bromley,et al.  The reliability of short-term measurements of heart rate variability. , 2005, International journal of cardiology.

[30]  S. Manuck,et al.  Heart Rate Variability Is Associated With Polymorphic Variation in the Choline Transporter Gene , 2005, Psychosomatic medicine.

[31]  Cheryl C. H. Yang,et al.  Effects of estrogen on gender-related autonomic differences in humans. , 2003, American journal of physiology. Heart and circulatory physiology.

[32]  B. V. Lipps Age and sex-related difference in levels of nerve growth factor in organs of Balb/c mice. , 2002, Journal of natural toxins.

[33]  M. Clayton,et al.  Modulation of nerve growth factor in peripheral organs by estrogen and progesterone , 2002, Neuroscience.

[34]  M. El-Mas,et al.  Testosterone Facilitates the Baroreceptor Control of Reflex Bradycardia: Role of Cardiac Sympathetic and Parasympathetic Components , 2001, Journal of cardiovascular pharmacology.

[35]  Jagmeet P. Singh,et al.  Genetic factors contribute to the variance in frequency domain measures of heart rate variability , 2001, Autonomic Neuroscience.

[36]  Enrico Alleva,et al.  Psychosocial vs. “physical” stress situations in rodents and humans Role of neurotrophins , 2001, Physiology & Behavior.

[37]  A. Kadish,et al.  Relationship of Heart Rate Variability to Parasympathetic Effect , 2001, Circulation.

[38]  J. Gorman,et al.  Heart rate variability in depressive and anxiety disorders. , 2000, American heart journal.

[39]  Hagit Cohen,et al.  Power Spectral Analysis of Heart Rate Variability in Psychiatry , 1999, Psychotherapy and Psychosomatics.

[40]  K. Livak,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.

[41]  Jagmeet P. Singh,et al.  Heritability of heart rate variability: the Framingham Heart Study. , 1998, Circulation.

[42]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[43]  L. Lorigados,et al.  Nerve growth factor levels in normal human sera , 1996, Neuroreport.

[44]  D. Levy,et al.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. , 1996, Circulation.

[45]  M Malik,et al.  Short- and long-term assessment of heart rate variability for risk stratification after acute myocardial infarction. , 1996, The American journal of cardiology.

[46]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[47]  R. Rylett,et al.  Differential Effects of Nerve Growth Factor on Expression of Choline Acetyltransferase and Sodium‐Coupled Choline Transport in Basal Forebrain Cholinergic Neurons in Culture , 1996, Journal of neurochemistry.

[48]  A. Dart,et al.  Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function. , 1995, Cardiovascular research.

[49]  M Kumashiro,et al.  Power Spectral Analysis of Heart Rate Variability in Healthy Young Women During the Normal Menstrual Cycle , 1995, Psychosomatic medicine.

[50]  A. Porta,et al.  Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. , 1994, Circulation.

[51]  I. Meredith,et al.  Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. , 1991, The New England journal of medicine.

[52]  A. Malliani,et al.  Cardiovascular Neural Regulation Explored in the Frequency Domain , 1991, Circulation.

[53]  R J Cohen,et al.  Beat to beat variability in cardiovascular variables: noise or music? , 1989, Journal of the American College of Cardiology.

[54]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[55]  R. Cohen,et al.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.

[56]  B Lown,et al.  Neural activity and ventricular fibrillation. , 1976, The New England journal of medicine.

[57]  Q. Regestein,et al.  Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management. , 1976, The New England journal of medicine.

[58]  R. Steer,et al.  Manual for the Beck Anxiety Inventory. , 2013 .

[59]  A. De Luca,et al.  Effects of castration on the expression of the NGF and TrkA in the vas deferens and accessory male genital glands of the rat. , 2009, European journal of histochemistry : EJH.

[60]  J. Feldon,et al.  Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice , 2006, Journal of Neural Transmission.

[61]  C. Donley Literary Genres in the Diagnostic and Statistical Manual of Mental Disorders. , 2005 .

[62]  M. Fiore,et al.  Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? , 2004, Progress in brain research.

[63]  T Foitzi,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .

[64]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[65]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.